Based in South San Francisco, California, Tenaya Therapeutics is at the forefront of biotechnology with a focus on developing innovative therapies for heart disease. Leveraging cutting-edge platforms in cellular regeneration, gene therapy, and precision medicine, Tenaya is working on a range of treatments. These include gene therapies for specific types of cardiomyopathy and a small molecule for heart failure, alongside pioneering efforts in cardiac regeneration to help patients recover from heart failure caused by myocardial infarction. Founded in 2016, Tenaya aims to transform the landscape of cardiovascular disease treatment.

TNYA Articles